Ovarian preservation in stage I low-grade endometrial stromal sarcomas

Obstetrics and Gynecology

Volumn 106, Issue 6, 2005, Pages 1304-1308

  Li, Andrew J ^a   Giuntoli II, Robert L ^b   Drake, Richard ^b   Byun, Sharon Young ^b   Rojas, Francisco ^b   Barbuto, Denise ^b   Klipfel, Nancy ^b   Edmonds, Pamela ^b   Miller, David S ^b   Karlan, Beth Y ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GESTAGEN; PROGESTERONE RECEPTOR;

ABDOMEN; ADJUVANT CHEMOTHERAPY; ADULT; AGE; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DATA ANALYSIS; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG; OVARY; OVARY FUNCTION; PELVIS; PRESERVATION; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; STUDENT T TEST; VAGINAL HYSTERECTOMY;

EID: 27944459686     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000185511.91694.1e     Document Type: Article

References (28)

1. Norris HJ, Taylor H. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 1966;19:755-66.
2. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol 1996;62:254-9.
3. Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001;81:160-5.
4. Blom R, Malmstrom H, Guerrieri C. Endometrial stromal sarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 17 cases. Int J Gynecol Cancer 1999;9:98-104.
5. Huang KT, Chen CA, Tseng GC, Chen TM, Cheng WF, Hsieh CY. Endometrial stromal sarcoma of twenty cases. Acta Obstet Gynecol Scand 1996;75:551-5.
6. Larson B, Silfversward C, Nilsson B, Pettersson F. Endometrial stromal sarcoma of the uterus: a clinical and histopathological study. The Radiumhemmet series 1936-1981. Eur J Obstet Gynecol Reprod Biol 1990;35:239-49.
7. Blank SV, Mikuta JJ. Low-grade stromal sarcoma: confusion and clarification. Postgraduate Obstet Gynecol 2001;21:1-4.
8. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL. Treatment of endometrial stromal tumors. Gynecol Oncol 1990;36:60-5.
9. Young R, Prat J, Scully RE. Endometrioid stromal sarcomas of the ovary: a clinicopathologic analysis of 23 cases. Cancer 1984;53:1143-55.
10. Chu MC, Mor G, Lim C, Zheng W, Parkash V, Schwartz PE. Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 2003;90:170-6.
11. Reich O, Regauer S, Urdl W, Lahousen M, Winter R. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 2000;82:1030-4.
12. Navarro D, Cabrera JJ, Leon L, Chirino R, Fernandez L, Lopez A, et al. Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness. J Steroid Biochem Mol Biol 1992;41:589-96.
13. Balleine RL, Earls PJ, Webster LR, Mote PA, deFazio A, Harnett PR, et al. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. Int J Gynecol Pathol 2004;23:138-44.
14. Morice P, Leblanc E, Rey A, Baron M, Querleu D, Blanchot J, et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique). Hum Reprod 2005;20:1379-85.
15. Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 2002;87:1-7.
16. Giuntoli RL 2nd,Metzinger DS,DiMarco CS, Cha SS, Sloan JA, Keeney GL, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 2003;89:460-9.
17. Karlan BY, Baldwin RL, Lopez-Luevanos E, Raffel LJ, Barbuto D, Narod S, et al. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening. Am J Obstet Gynecol 1999;180:917-28.
18. Kolassa JE. A comparison of size and power calculations for the Wilcoxon statistic for ordered categorical data. Stat Med 1995;14:1577-81.
19. Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996;63:247-53.
20. Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr,et al Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol 2004;95:632-6.
21. Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR. Primary uterine endometrial stromal neoplasms: a clinicopathologic study of 117 cases. Am J Surg Pathol 1990;14:415-38.
22. Mansi JL, Ramachandra S, Wiltshaw E, Fisher C. Endometrial stromal sarcomas. Gynecol Oncol 1990;36:113-8.
23. Burke C, Hickey K. Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue. Obstet Gynecol 2004;104:1182-4.
24. Mesia AF, Demopoulos RI. Effects of leuprolide acetate on low-grade endometrial stromal sarcoma. Am J Obstet Gynecol 2000;182:1140-1.
25. Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF, et al. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 2003;20:87-93.
26. Scribner DR Jr, Walker JL. Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace. Gynecol Oncol 1998;71:458-60.
27. Li AJ, Baldwin RL, Karlan BY. Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures. Am J Obstet Gynecol 2003;189:22-7.
28. Kelley TW, Borden EC, Goldblum JR. Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical study. Appl Immunohistochem Mol Morphol 2004;12:338-41.